Cytosol currently has three proprietary products with new drug application approvals: TriCitrasol, noClot-50 and Rejuvesol.
Read the Biomet news release.
Read other coverage on Biomet.
-Biomet’s Indiana Facility to Expand
-Biomet Sports Medicine Mobile Learning Center to Provide Product Demonstration and Education
-Biomet Announces 4Q FY 2010 Financial Results
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
